CLSL
Crop Life Science Ltd
Each stock's 10,000-path forecast, rendered as light.
Crop Life Science Ltd (CLSL) Stock Analysis & Case Study
What the numbers say about CLSL, and the method behind each one.
Crop Life Science Ltd (CLSL) trades at ₹78,on the numbers it screens weak, a Downstox Snapshot Score of 44/100.
On the numbers, Crop Life Science Ltd (CLSL) screens weak, a Downstox Snapshot Score of 44/100, weighing fairly valued at 20.3× earnings, ROE of 8.2%, a 49% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
CLSL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How CLSL ranks against the 2,982 companies in our screener
- CLSL's market cap of 134 Cr ranks in the 20th percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- CLSL's book value of ₹49 ranks in the 36th percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- CLSL's promoter holding of 70.0% ranks in the 72nd percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- CLSL's 3-year profit (PAT) growth of 17.0% ranks in the 49th percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- CLSL's 3-year revenue growth of 17.0% ranks in the 63rd percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- CLSL's debt-to-equity ratio of 0.68x is lower than 27% of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
Is CLSL overvalued? CLSL P/E vs peers
CLSL trades at 20.3× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
CLSL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.9y of CLSL history (13%/yr drift, 51%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| CLSL 2027 | ₹39 | ₹76 | ₹146 | -2% |
| CLSL 2028 | ₹29 | ₹74 | ₹191 | -4% |
| CLSL 2029 | ₹23 | ₹73 | ₹234 | -6% |
| CLSL 2030 | ₹18 | ₹71 | ₹274 | -8% |
| CLSL 2031 | ₹16 | ₹70 | ₹312 | -9% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability CLSL goes up, or doubles?
The bull case for CLSL
- CLSL's P/E of 20.3x is lower than 57% of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹234.
The bear case & risks
- CLSL's return on equity of 8.2% ranks in the 39th percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
- High historical volatility (51%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹23.
CLSL volatility & expected range, how bumpy is the ride?
Over the last 2.9 years CLSL compounded at 13%/year with annualized volatility of 51%. That volatility implies a 1-year 80% range of ₹39-₹146, the honest backbone behind any single price target.
CLSL price forecast, the full 60-month probability fan
CLSL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds CLSL hits common targets within the simulated horizon?
Full multi-horizon detail on the CLSL price target & forecast page.
CLSL Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. CLSL scores 5/8, mixed financial health.
About Crop Life Science Ltd: sector, index & market-cap context
Crop Life Science Ltd (CLSL) is a small-cap NSE-listed company, with a market capitalisation of ₹134 Cr. See more stocks on our screener.
How the CLSL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Crop Life Science Ltd's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
CLSL analysis, FAQs
Is Crop Life Science Ltd (CLSL) a good buy?
On the numbers, Crop Life Science Ltd (CLSL) screens weak, a Downstox Snapshot Score of 44/100, weighing fairly valued at 20.3× earnings, ROE of 8.2%, a 49% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is CLSL overvalued or undervalued?
CLSL trades at 20.3× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the CLSL share price target for 2031?
CLSL's probability-weighted 2031 median target is ₹70, with an 80% range of ₹16-₹312 (10,000-path Monte-Carlo).
What is the probability CLSL doubles in 5 years?
The modelled probability of CLSL reaching ₹154 (2×) within 5 years is 25%.
What is the bull case for CLSL?
CLSL's P/E of 20.3x is lower than 57% of the 2,982 NSE companies in our screener, as of 14 Aug 2026.
What are the risks in CLSL?
CLSL's return on equity of 8.2% ranks in the 39th percentile of the 2,982 NSE companies in our screener, as of 14 Aug 2026. High historical volatility (51%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
More on CLSL
For information and education only. Downstox is a data and analytics platform, not a SEBI-registered Research Analyst or Investment Adviser. Nothing here is investment advice or a recommendation to buy, sell or hold any security. Any scores, ranks, targets or scenarios are model estimates shown with their method, not forecasts or assured outcomes. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing.